The F2-Isoprostane 8-Epiprostaglandin F2αIncreases Platelet Adhesion and Reduces the Antiadhesive and Antiaggregatory Effects of NO

Authors:

Abstract
—F2-isoprostanes are prostaglandin (PG) isomers produced in vivo through free radical–catalyzed peroxidation of arachidonic acid, which may affect platelet function. The current study investigated the effects of 8-epiprostaglandin F2α(8-epi-PGF2α) on critical events of platelet activation. A dose-dependent increase in platelet adhesion to fibrinogen- and plasma-coated microwells by 8-epi-PGF2α(1 to 1000 nmol/L) was observed when resting platelets (plasma from 1.3±0.2% to 5.5±0.2%, EC50of 48 nmol/L; fibrinogen from 3.3±0.3% to 6.4±0.2%, EC50of 35 nmol/L; mean±SEM, n=8,P2αin resting platelets (from 64.8±2.1% to 83.9±1.3%; n=5,P2α(from 48.5±3.1% to 63.1±2.0%,P2α, 30.8±6.9%; n=14,P2α, 30.7±5.3%; n=15,P2α. In conclusion, F2-isoprostanes may participate in oxidative injury by inducing platelet activation and by reducing the antiplatelet activity of NO: increased platelet adhesiveness and expression of the fibrinogen receptor are induced by nanomolar amounts of 8-epi-PG-F2α. Platelet secretion and aggregation can also be induced in the presence of platelet agonists.

This publication has 57 references indexed in Scilit: